Clinical Research
Copyright ©The Author(s) 2002.
World J Gastroenterol. Jun 15, 2002; 8(3): 575-576
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.575
Table 1 Changes of DD and vWF levels in patients with UC (-x±s)
nDD (mg/l)vWF (%)
controls200.27 ± 0.11102.75 ± 34.91
UC
active170.69 ± 0.41ab142.71 ± 45.96a
Inactive120.48 ± 0.29a135.00 ± 26.25a
Table 2 The levels of DD and vWF in different sex and scope of disease (-x±s)
nDD (mg/l)vWF (%)
Sex
Male130.58 ± 0.11142.84 ± 42.85
Female160.55 ± 0.15138.75 ± 36.75
Scope of disease
Rectum-sigmoid150.58 ± 0.27137.11 ± 36.87
Left-side90.59 ± 0.26138.78 ± 42.22
Colon50.63 ± 0.41143.60 ± 51.60